跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 487 条关于
“ATAC”
全部
487
临床试验
291
药物
107
机构
9
资讯
80
6个月前
Heidelberg Pharma Advances Novel ATAC Technology Platform with Multiple Cancer Candidates in Clinical Development
7个月前
Heidelberg Pharma Receives Milestone Payment from Takeda as ATAC-Based ADC Enters Phase I/II Trial
去年
Heidelberg Pharma's HDP-101 Shows Promise in Relapsed Multiple Myeloma
9个月前
Heidelberg Pharma Appoints Dr. Dongzhou Jeffery Liu as New CEO Amid Leadership Transition
去年
Heidelberg Pharma Reports Promising Clinical Progress with HDP-101 in Multiple Myeloma and Advances HDP-102 into Clinical Trials
22天前
Heidelberg Pharma and Huadong Medicine Expand Partnership to Co-Develop Next-Generation Antibody Drug Conjugates
11个月前
Heidelberg Pharma's HDP-101 ADC Receives FDA Fast Track Designation for Multiple Myeloma Treatment
6个月前
Heidelberg Pharma Secures $45 Million Through Modified Licensing Agreement with HealthCare Royalty and Soleus Capital
24天前
Heidelberg Pharma and Huadong Medicine Receive NMPA Approval for Phase Ib/II Trial of BCMA-Targeting ADC HDP-101 in Multiple Myeloma
去年
Heidelberg Pharma Advances into Cohort 7 in Phase I/IIa Study for Multiple Myeloma Treatment
第 1 页,共 8 页
上一页
下一页